Your browser doesn't support javascript.
loading
A potent PGK1 antagonist reveals PGK1 regulates the production of IL-1ß and IL-6.
Liao, Liping; Dang, Wenzhen; Lin, Tingting; Yu, Jinghua; Liu, Tonghai; Li, Wen; Xiao, Senhao; Feng, Lei; Huang, Jing; Fu, Rong; Li, Jiacheng; Liu, Liping; Wang, Mingchen; Tao, Hongru; Jiang, Hualiang; Chen, Kaixian; Diao, Xingxing; Zhou, Bing; Shen, Xiaoyan; Luo, Cheng.
Afiliación
  • Liao L; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Dang W; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Lin T; Department of Pharmacology & the Key Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai 201203, China.
  • Yu J; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Liu T; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Li W; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Xiao S; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Feng L; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Huang J; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Fu R; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Li J; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Liu L; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Wang M; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Tao H; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Jiang H; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Chen K; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Diao X; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Zhou B; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Shen X; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Luo C; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Acta Pharm Sin B ; 12(11): 4180-4192, 2022 Nov.
Article en En | MEDLINE | ID: mdl-36386479
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Acta Pharm Sin B Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Acta Pharm Sin B Año: 2022 Tipo del documento: Article País de afiliación: China